Dr. Chase on Challenges Facing Gynecologic Cancers

Dana M. Chase, MD, FACOG
Published: Tuesday, Apr 18, 2017



Dana M. Chase, MD, FACOG, an associate professor at Creighton University, University of Arizona College of Medicine, and gynecologic oncologist with Arizona Oncology, discusses challenges facing gynecologic cancers.

Endometrial cancer is most often cured with surgery, leaving only a small patient population that has recurrent disease. Finding funding for large randomized studies with that small patient group is more difficult, explains Chase.

Similarly, cervical and vulvar cancer are not as common, creating a challenge for getting drugs approved in those patients.

SELECTED
LANGUAGE


Dana M. Chase, MD, FACOG, an associate professor at Creighton University, University of Arizona College of Medicine, and gynecologic oncologist with Arizona Oncology, discusses challenges facing gynecologic cancers.

Endometrial cancer is most often cured with surgery, leaving only a small patient population that has recurrent disease. Finding funding for large randomized studies with that small patient group is more difficult, explains Chase.

Similarly, cervical and vulvar cancer are not as common, creating a challenge for getting drugs approved in those patients.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Publication Bottom Border
Border Publication
x